October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance of the society’s task force recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs).
October 15, 2007 - Oncologists need to consider the affects on the cardiovascular system when treating early breast cancer, according to a review article in the Oct. 9 issue of the Journal of the American College of Cardiology.
October 15, 2007 - Siemens Medical Solutions Molecular Imaging Division will introduce the new Symbia E series single ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Siemens Medical Solutions Molecular Imaging Division's Symbia E series single photon emission computed tomography (SPECT ...
October 15, 2007 - Low-dose coronary CT angiogram (CCTA) could be better for testing asymptomatic patients for heart attack risk, according to researchers at Cedars-Sinai Medical Center, Los Angeles, CA.
October 11, 2007 - GE Healthcare, a unit of General Electric Company, today announced that it has completed the ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 10, 2007 - Medtronic Inc. announced that an FDA advisory committee has recommended the Endeavor drug-eluting ...
Carestream Health’s KODAK DIRECTVIEW CR Mammography feature adds mammography applications to its CR platforms along with ...
October 10, 2007 - Premier Purchasing Partners, LP, announced new agreements have been awarded for diagnostic imaging ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 10, 2007 - A new technique for capturing images of chest veins eases diagnosis of venous diseases, according to ...
October 9, 2007 - Physio-Control Inc., a wholly owned subsidiary of Medtronic, Inc., will introduce the LUCAS Chest Compression System in the United States through an exclusive distribution partnership with JOLIFE AB, expanding the reach of its emergency medicine device portfolio.
October 9, 2007 – Medtronic Inc. today announced that it has begun enrolling in the PRECEDE-HF clinical trial that will evaluate Medtronic’s proprietary Cardiac Compass and OptiVol Fluid Status Monitoring features to determine whether cardiac trend data may help physicians prevent heart failure hospitalizations or deaths compared to standard clinical assessment alone.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 9, 2007 - Biophan Technologies Inc., a developer of biomedical technology, announced it has closed the $11 ...
October 9, 2007 - Physio-Control Inc., a wholly owned subsidiary of Medtronic, Inc., today announced that the LUCAS Chest Compression System is available in the U.S. through an exclusive distribution partnership with JOLIFE AB, expanding its reach of its emergency medicine device portfolio.
October 9, 2007 - Ascent Healthcare Solutions announced that the FDA has cleared two Ascent 510(k) submissions to ...
October 15, 2007
